Vaccines, blood, antisera, toxins and cultures in United Kingdom

About

Exports In 2022, United Kingdom exported $6.05B in Vaccines, blood, antisera, toxins and cultures, making it the 12th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 11th most exported product in United Kingdom. The main destination of Vaccines, blood, antisera, toxins and cultures exports from United Kingdom are: United States ($2.48B), France ($514M), Japan ($318M), Germany ($314M), and Netherlands ($282M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of United Kingdom between 2021 and 2022 were United States ($348M), France ($202M), and Japan ($167M).

Imports In 2022, United Kingdom imported $9.99B in Vaccines, blood, antisera, toxins and cultures, becoming the 10th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 11th most imported product in United Kingdom. United Kingdom imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($2.72B), Germany ($1.6B), Switzerland ($1.33B), United States ($1.28B), and Ireland ($997M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for United Kingdom between 2021 and 2022 were Ireland ($277M), United States ($205M), and United Kingdom ($150M).

Latest Trends

September 2024

About

Overview In September 2024 United Kingdom's Vaccines, blood, antisera, toxins and cultures exports accounted up to £429M and imports accounted up to £858M, resulting in a negative trade balance of £428M. Between September 2023 and September 2024 the exports of United Kingdom's Vaccines, blood, antisera, toxins and cultures have increased by £31.9M (8.04%) from £397M to £429M, while imports decreased by £-19M (-2.17%) from £877M to £858M.

Destinations In September 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to United States (£163M), France (£52.4M), Netherlands (£36M), Italy (£21.9M), and Belgium (£16.6M), and were imported mostly from Belgium (£448M), United States (£83.3M), Switzerland (£75.3M), Germany (£58.8M), and Ireland (£57M).

Growth In September 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to South Korea (£216M or 6.77k%), France (£40.2M or 580%), and Ireland (£38.4M or 344%). In September 2024, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by a decrease in imports from Italy (£-37M or -88.2%), Switzerland (£-15.9M or -19.1%), and China (£-8.72M or -84.6%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (September 2023 - September 2024)£31.9M(8.04%)

IMPORT GROWTH (September 2023 - September 2024)£-19M(-2.17%)

MAIN EXPORTER (September 2024)London Heathrow Airport£290M

MAIN DESTINATION (September 2024)United States£163M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for United Kingdom. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download